Page last updated: 2024-11-04

rolipram and Liver Diseases

rolipram has been researched along with Liver Diseases in 1 studies

Liver Diseases: Pathological processes of the LIVER.

Research Excerpts

ExcerptRelevanceReference
"Rolipram is a specific type IV phosphodiesterase inhibitor that suppresses the activity of immune cells and the production of pro-inflammatory cytokines."1.33Specific type IV phosphodiesterase inhibitor ameliorates thioacetamide-induced liver injury in rats. ( Hatakeyama, N; Horikawa, Y; Jin, M; Komatsu, K; Konishi, N; Matsuhashi, T; Odashima, M; Ohba, R; Otaka, M; Oyake, J; Sato, T; Wada, I; Watanabe, S, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Matsuhashi, T1
Otaka, M1
Odashima, M1
Jin, M1
Komatsu, K1
Konishi, N1
Wada, I1
Sato, T1
Horikawa, Y1
Ohba, R1
Oyake, J1
Hatakeyama, N1
Watanabe, S1

Other Studies

1 other study available for rolipram and Liver Diseases

ArticleYear
Specific type IV phosphodiesterase inhibitor ameliorates thioacetamide-induced liver injury in rats.
    Journal of gastroenterology and hepatology, 2005, Volume: 20, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Liver Diseases; Male; Phosphodiesterase Inhibitors;

2005